Prosecution Insights
Last updated: October 04, 2026

Anteris Technologies Corporation

Technology area: Medical Devices & Mechanical Engineering

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Analysis

Anteris Technologies Corporation is currently managing 1 pending office action in the Medical Devices & Mechanical Engineering technology area. This prosecution involves 1 distinct examiner and is situated within 1 distinct art unit. The presence of only 1 pending action suggests a highly specific or early-stage engagement with the patent office for the company's current filings in this technology sector. This focus allows for a concentrated effort on a single set of technical requirements.

The busiest examiner for this portfolio is GANESAN, SUBA, who is handling 1 busiest examiner pending action. Since GANESAN, SUBA is the only examiner across the 1 distinct art unit, the company's immediate success in Medical Devices & Mechanical Engineering is tied to this single individual's examination. Practitioners should focus on the specific requirements of the 1 pending office action to ensure the portfolio moves forward effectively. Monitoring the patterns of GANESAN, SUBA will be essential for navigating the current prosecution landscape.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
GANESAN, SUBA 1 73.8% +13.4%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18410796 PROSTHETIC HEART VALVES GANESAN, SUBA —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18410796 PROSTHETIC HEART VALVES GANESAN, SUBA —

Top Art Units

Art UnitApps
3774 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18410796 PROSTHETIC HEART VALVES GANESAN, SUBA 3774 §102§103 Non-Final OA — Pending Jan 11, 2024

Managing Anteris Technologies Corporation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month